ROMEDLACNOR6
ROMEDLACNOR6
Med Life SA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2024 | 2023 | Change % |
|---|---|---|---|
| Total Revenue | 2.715.456.439 | 2.210.435.348 | 22.8% |
| Cost of Revenue | 1.144.988.242 | 932.911.812 | 22.7% |
| Gross Profit | 1.570.468.197 | 1.277.523.536 | 22.9% |
| 1.418.855.300 | 1.183.317.524 | 19.9% | |
| Operating Income | 151.612.897 | 94.206.012 | 60.9% |
| Pretax Income | 44.316.764 | 4.299.484 | 930.7% |
| Net Income Common Stockholders | 25.545.592 | 3.684.292 | 593.4% |
| -- | -- | -- | |
| -- | -- | -- |